Eva Chalas, MD, FACOG, FACS
Director of Clinical Cancer Services; Vice-Chair, Department of Obstetrics and Gynecology; Chief, Division of Gynecologic Oncology
Academic Faculty Appointments
Professor, Stony Brook University, School of Medicine
Winthrop University Hospital Department of Obstetrics and Gynecology 259 First Street Mineola, NY 11501
Dr. Eva Chalas obtained her MD degree from Stony Brook University, School of Medicine, completed her residency training in Obstetrics and Gynecology at its Medical Center and fellowship at Memorial Sloan-Kettering Cancer Center in 1987, where she served as an American Cancer Society Fellow. Dr. Chalas is Board Certified in Obstetrics and Gynecology and in Gynecologic Oncology, and is a Fellow in American College of Obstetrics and Gynecology (ACOG) and of American College of Surgeons (ACS).
Dr. Chalas has held leadership positions in ACS, serves on the board of Gynecologic Cancer Foundation (GCF), and is the Secretary–Treasurer of the Society of Gynecologic Oncology (SGO). Dr. Chalas has also been a member of numerous committees of ACOG, most recently serving on the Nominations Committee for national officers, and is the Vice-Chair of ACOG District II.
Dr. Chalas' many awards include: awards given to her by grateful patients and their family members, selection to the “Top Doctors” lists, “Local Legend from New York” award from the American Medical Women’s Association, the National Leadership award by the National Republican Congressional Committee and a number of excellence in teaching awards.
Dr. Chalas is the Director of Clinical Cancer Services and Vice-Chair of the Department of Obstetrics and Gynecology at Winthrop University Hospital, where she practices, caring for women with gynecologic cancers or complex gynecologic problems. She holds the academic rank of Professor at the Stony Brook University School of Medicine.
Description of Research Interests/Activities
Dr. Chalas is involved in clinical research, particularly via the collaborative trials of the Gynecologic Oncology Group supported by NCI grants, and outreach research supported by grants from the Department of Health in New York State. Dr. Chalas has published and lectured extensively, particularly on prevention and treatment of gynecologic cancers.
Areas of Experience
Research Team Members
The Gynecologic Oncology Division clinical and research staff includes Eva Chalas, MD, Jeannine Villella, DO, Kent Chan, MD, Jean Farrell, RN, Eleanor Colbert, RN, Cindy Pederson-Goetz, RN, Linda Milana, RN and Kristine Prazak, PA. Dr. Jeannine Villella is the Principal Investigator for GOG at Winthrop University Hospital, which is an affiliate site for Stony Brook University. Both she and Dr. Chan are Board Certified in Obstetrics and Gynecology and Gynecologic Oncology, and have collaborated for more than five years.
Clinical Practice and Interests
-Managing Ovarian Cancer
-Minimally invasive surgery
-Conditions in women with history of breast cancer
1. Schreiber Z. J., Liang S, Pearl M, Chalas E, and Tornos C. “Helpful histologic features of serous carcinoma during intraoperative diagnosis of ovarian tumors.” Modern Pathology 22, supplement 1, 224, 2008
2. DiSilvestro PA, Fischer M, Pearl ML, Buhl A, Chalas E, Valea F. "Pilot phase 2 trial of 4 months of maintenance pegylated liposomal doxorubicin in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy" Gynecol Obstet Invest 63:1-6 2007
3. Howell NR, Zheng W, Cheng L, Tornos C, Kane P, Pearl ML, Chalas E, Liang SX. Carcinomas of ovary and lung with clear cell features: Differential diagnosis based on immunohistochemistry. Int J Gynecol Pathol 26:134-140, 2007
4. Liang S, Stone G, Chalas E, Pearl ML, Callan F, Zheng W. A high-grade uterine leiomyosarcoma with human chorionic gonadotropin production. Int J Gynecol Pathol 25(3): 257-261, 2006
5. Becker K, Pancoska P, Concin N, VanDenHeuval K, Slade N, Fischer M, Chalas E, Moll U. Patterns of p73 N-terminal isoform expression and p53 status have prognostic value in gynecological cancers. IntJOncol 29(4): 889-902, 10/2006
6. Chalas E, Costantino JP, Wickerham DL, Wolmark N, Lewis G, Bergman C, Runowicz C. Benign gynecologic conditions among participants in the breast cancer prevention trial. Obstet Gynecol 192, 1230-9, 2005.
7. Villella J, Chalas E. Optimizing treatment of elderly patients with ovarian cancer: improving their enrollment in clinical trials. DrugsAging 22(2): 95-100, 2005
8. Bettes BA, Chalas E, Coleman V, Schulkin J. Heavier workload, less personal control: Impact of delivery on obstetrician/gynecologists’ career satisfaction. Am J Obstet Gynecol 190(3): 851-857, 2004.
9. Chaudhry TL, Valea FA, Pearl ML, DiSilvestro PA, Fischer M, Chalas E. Primary care experience on a university-based oncology service. Prim Care Update Ob/Gyns 9(2): 57-60, 2002.
10. Pearl ML, Villella JA, Valea FA, DiSilvestro PA, Chalas E. Outcomes of endometrial cancer patients undergoing surgery with gynecologic oncology involvement. Obstet Gynecol 100 (4): 724-729, 2002.
11. Villella JA, Schneider J, Chalas E. Long-term surveillance of previously treated breast cancer survivors by primary care physicians. Prim Care Update Ob/Gyns 9(3): 110-15, 2002.
12. Inagami M, Valea FA, Chalas E, Chumas J, Pearl MP. Microinvasive cervical adenocarcinoma. Int J Surg Invest (in press).
13. Villella J, Chaudhry T, Pearl ML, Valea FA, DiSilvestro PA, Pollack S, Chalas E. Comparison of tolerance of combination Carboplatin and Paclitaxel chemotherapy by age in women with ovarian cancer. Gynecol Oncol 86(3): 316-322, 2002.
14. Pearl MP, Buhl A, DiSilvestro PA, Valea FV, Chalas E. Superior Vena Cava syndrome. Prim Care Update Ob/Gyns 9(5): 160-163, 2002.
15. Pearl ML, Frandina M, Mahler L, Valea FA, DiSilvestro PA, Chalas E. A randomized controlled trial of regular diet as the first meal in gynecologic oncology patients undergoing intra-abdominal surgery. Obstet Gynecol 100(2): 230-234, 2002.